- Dyne Therapeutics (NASDAQ:DYN) announces that Romesh Subramanian has chosen to step down as chief scientific officer (CSO) of the company citing personal reasons.
- Concurrently, Oxana Beskrovnaya, who has served as Dyne’s senior vice president, head of research since January 2020, has been appointed CSO.
- Prior to joining Dyne, Beskrovnaya served as head of musculoskeletal and renal research in Sanofi’s rare disease and neurological unit.
- The company said that Romesh will continue to serve as an advisor to Dyne.